Skip to main content
. 2025 Aug 22;40(1):185. doi: 10.1007/s00384-025-04979-7

Table 2.

Surgical and pathological outcomes of patients with low rectal cancer

Characteristics Underweight (n = 53) Normal weight (n = 589) Overweight (n = 336) Obesity (n = 61) P value
Surgical characteristics
Surgical approach, No. (%) 0.897
  Open 14 (26.4) 185 (28.8) 103 (30.7) 19 (31.1)
  Laparoscopic 39 (73.6) 457 (71.2) 233 (69.3) 42 (68.9)
Conversion to open surgery, No. (%) a 2 (3.8) 12 (1.9) 3 (0.9) 2 (3.3) 0.162
Type of surgery, No. (%) 0.004
  Low anterior resection 40 (76.9) 359 (61.4) 206 (61.5) 26 (43.3)
  Intersphincteric resection 4 (7.7) 47 (8.0) 30 (9.0) 3 (5.0)
  Abdominoperineal resection 8 (15.4) 179 (30.6) 99 (29.6) 31 (51.7)
Anal sphincter preservation b 45 (84.9) 409 (69.4) 237 (70.5) 30 (49.2)  < 0.001
Diverting ostomy, No. (%) c 38 (84.4) 314 (76.8) 181 (76.4) 22 (73.3) 0.637
Type of diverting ostomy, No. (%) 0.808
  Ileostomy 38 (100) 303 (96.5) 170 (93.9) 21 (95.5) 0.298
  Colostomy 0 11 (3.5) 11 (6.1) 1 (4.5)
Combined multivisceral resection, No. (%) 3 (5.7) 15 (2.5) 5 (1.5) 1 (1.6) 0.222
Operative time (min), median(IQR) 150 (120, 196) 180 (145, 225) 191 (165, 244.5) 217.5 (183.5, 252.5)  < 0.001
Estimated blood loss (ml), median (IQR) 50 (20, 100) 50 (50, 100) 50 (40, 100) 100(50, 100) 0.001
Intraoperative complications, No. (%) 0 5 (0.8) 12 (3.6) 2 (3.3) 0.014
Pathological outcomes
pT stage, No. (%) 0.10
  0/Tis 7 (13.2) 77 (13.1) 49 (14.6) 7 (11.5)
  1 6 (11.3) 51 (8.7) 40 (11.9) 3 (4.9)
  2 20 (37.7) 205 (34.8) 125 (37.2) 24 (39.3)
  3 11 (20.8) 229 (38.9) 103 (30.7) 24 (39.3)
  4 9 (17.0) 27 (4.6) 19 (5.7) 3 (4.9)
pN stage, No. (%) 0.672
  0 36 (67.9) 436 (74.0) 261 (77.7) 44 (72.1)
  1 12 (22.6) 117 (19.9) 58 (17.3) 14 (23.0)
  2 5 (9.4) 36 (6.1) 17 (5.1) 3 (4.9)
pTNM stage, No. (%) 0.725
0/pCR 7 (13.2) 73 (12.4) 47 (14.0) 7 (11.5)
  I 20 (37.7) 208 (35.3) 133 (39.6) 23 (37.7)
  II 9 (17.0) 154 (26.1) 82 (24.4) 14 (23.0)
  III 17 (32.1) 154 (26.1) 74 (22.0) 17 (27.9)
No. of retrieved lymph nodes, median (IQR) 14 (11, 20) 13 (9, 17) 12 (9, 16) 12 (7, 14) 0.027
Histopathology, No. (%) 0.314
  Adenocarcinoma 52 (98.1) 557 (94.6) 310 (92.3) 57 (93.4)
  Mucinous adenocarcinoma/Signet-ring cell carcinoma 1 (1.9) 32 (5.4) 26 (7.7) 4 (6.6)
Tumor differentiation, No. (%) 0.551
  Well differentiated 2 (3.8) 46 (7.8) 28 (8.3) 7 (11.5)
  Moderately differentiated 36 (67.9) 327 (55.5) 191 (56.8) 38 (62.3)
  Poorly differentiated 4 (7.5) 41 (7.0) 18 (5.4) 3 (4.9)
  Undifferentiated 0 3 (0.5) 1 (0.3) 1 (1.6)
  Unknown 11 (20.8) 172 (29.2) 98 (29.2) 12 (19.7)
TME quality, No. (%) d 0.015
  Complete 44 (88.0) 443 (85.7) 259 (85.8) 41 (78.8)
Nearly complete 5 (10.0) 63 (12.2) 35 (11.6) 5 (9.6)
Incomplete 1 (2.0) 11 (2.1) 8 (2.6) 6 (11.5)
Length of PRM (mm), median (IQR)

116

(80,150)

125

(95, 150)

125

(95, 150)

125

(95, 150)

0.126
Length of DRM (mm), median (IQR) 22 (15, 35) 20 (13, 30) 20 (13, 30) 20 (13, 30) 0.579
Negative DRM, No. (%) 53 (100) 588 (99.8) 333 (99.1) 61 (100) 0.332
Negative CRM, No. (%) 52 (98.1) 632 (98.4) 333 (99.1) 61 (100) 0.305

Tis, Carcinoma in situ; pCR, pathological complete response; IQR, interquartile range; PRM, proximal resection margin; DRM, distal resection margin; CRM, circumferential resection margin; TME, total mesorectal excision; NA, not applicable.

a Data were obtained from 1032 patients. In the Underweight group, 1 patient underwent underwent transanal total mesorectal excision. In the Normal weight group, 2 patients underwent the Hartmann procedure, 1 underwent total proctocolectomy, and 1 underwent posterior pelvic resection. In the Overweight group, 1 patient underwent transanal total mesorectal excision. In the Obesity group, 1 patient underwent the Hartmann procedure.

b In the Underweight group, 40 patients underwent low anterior resection, 4 underwent intersphincteric resection, and 1 underwent transanal total mesorectal excision. In the Normal weight group, 359 patients underwent low anterior resection, 37 underwent intersphincteric resection, 2 underwent the Hartmann procedure, and 1 underwent posterior pelvic resection. In the Overweight group, 206 patients underwent low anterior resection, 30 underwent intersphincteric resection, and 1 underwent transanal total mesorectal excision. In the Obesity group, 26 patients underwent low anterior resection, 3 underwent intersphincteric resection, and 1 underwent the Hartmann procedure.

c Only patients who underwent sphincter-preserving surgery were included.

d Data were obtained from 921 patients.